Notice of Intent to Sole Source-Roche Chemistry Analyzer-Supplies-Service-Taos Picuris Service Unit
Indian Health Service · ALBUQUERQUE AREA INDIAN HEALTH SVC
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75H70726F80017-SoleSource in this department, oldest first.
- Aug 3, 2026 · this noticeSpecial Notice
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
NOTICE OF INTENT TO SOLE SOURCE Agency: Indian Health Service (IHS), Albuquerque Area Office PSC: DA10 NAICS: 334516 � Analytical Laboratory Instrument Manufacturing Notice Type: Special Notice � Intent to Sole Source Authority: FAR 6.302 1 � Only One Responsible Source Set Aside: Not Applicable 1. Description of Requirement The Indian Health Service (IHS), Albuquerque Area Office, Taos Picuris Health Center intends to issue a sole source commercial item procurement under FAR Part 12 to Roche Diagnostics Corporation for brand name only Roche COBAS Pure chemistry analyzer equipment, proprietary… (show all)
reagents, calibrators, controls, consumables, manufacturer maintenance, replacement parts, and technical/software support required for uninterrupted clinical chemistry operations. All Roche chemistry products and services are proprietary and must be acquired exclusively through Roche�s VA Federal Supply Schedule (FSS) Contract V797P 7347A, which is the only authorized federal contract vehicle for these items. Vendor: Roche Diagnostics Corporation UEI: JDMDFEZBYH36 Address: 9115 Hague Rd, P.O. Box 50457, Indianapolis, IN 46250 0457 Required brand name Roche items include, but are not limited to: � Roche COBAS Pure chemistry analyzer package � Clinical chemistry reagents, calibrators, QC materials, and assay cartridges � Required consumables and analyzer maintenance supplies � Refrigerated / frozen reagent shipping according to Roche specifications � Manufacturer preventive maintenance and field service support � 24 hour technical support and analyzer replacement if required � RPMS compatible connectivity, software integration, and firmware updates � All manufacturer approved QA, safety, and regulatory compliance items 2. Justification for Sole Source Market research confirms that Roche Diagnostics is the only responsible source authorized to provide Roche COBAS Pure analyzers, proprietary chemistry reagents, firmware, technical support, and maintenance. Roche retains all intellectual property rights associated with: � COBAS Pure chemistry analyzer architecture � Reagent formulations � Analyzer firmware and calibration files � Software connectivity and interface modules � RPMS integration protocols � Maintenance parts and service procedures Roche further confirmed that only VA FSS Contract V797P 7347A is authorized for federal procurement of COBAS Pure chemistry systems and associated consumables. No other vendor can legally manufacture, sell, service, or integrate Roche chemistry products, nor do any other vendors possess proprietary access or the ability to support existing workflows at Taos Picuris Health Center. Therefore, a sole source procurement is justified under FAR 6.302 1 � Only One Responsible Source. 3. This Notice Is Not a Request for Quotes This Special Notice solely announces the Government�s intent to negotiate on a sole source basis with Roche Diagnostics Corporation. No competitive solicitation will be issued. 4. Capability Statement Instructions Interested parties may submit a capability statement ONLY if they can demonstrate: � Legal authority to sell Roche brand name chemistry equipment and proprietary reagents � Authorization under VA FSS Contract V797P 7347A specifically � Certification to provide manufacturer authorized maintenance and technical support � Proven compatibility with existing Roche configured RPMS chemistry workflows � Ability to comply with all Roche shipping, storage, safety, and regulatory requirements Capability statements proposing alternative analyzers, third party reagents, substitute chemistry systems, or non Roche platforms will NOT be considered. 5. Response Deadline Responses must be submitted by: August 14, 2026 � 4:00 PM Mountain Time Send responses to: Raelynn Ray, Contract Specialist Indian Health Service � Albuquerque Area Office Email: raelynn.ray@ihs.gov Phone: 505 256 6757 6. Intended Award If no valid capability statements are received, the Government will award a sole source, firm fixed price, commercial item contract to Roche Diagnostics Corporation under FAR 6.302 1, using Roche�s VA FSS Contract V797P 7347A. 7. Period of Performance Base Year + Four (4) Option Years: � Base Year: 01/01/2027 � 12/31/2027 � Option Year 1: 01/01/2028 � 12/31/2028 � Option Year 2: 01/01/2029 � 12/31/2029 � Option Year 3: 01/01/2030 � 12/31/2030 � Option Year 4: 01/01/2031 � 12/31/2031 8. Contract Type Firm fixed price commercial item contract under FAR Part 12
Who won similar work
3 award notices on SAM.gov in the last 24 months. Matched by: Same office (ALBUQUERQUE AREA INDIAN HEALTH SVC), same NAICS 334516.
Single-winner award sizes (3): middle half $45K to $130K, median $61K; range $30K to $200K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| BIOMERIEUX INC | 1 | $200K | Dec 3, 2024 |
| Fisher Scientific Company · $TMO · $42.9B | 1 | $61K | Nov 7, 2024 |
| BIGHORN RIDGERUNNERS, LLC | 1 | $30K | Jun 16, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $TMO reported $42.9B revenue in FY2025. The median single-winner award in these 3 past awards, $61K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Jun 16, 2025BIGHORN RIDGERUNNERS, LLC$30KSolicitation 75H70725Q00101 - Accufit9000 Pro for Zuni Comprehensive Community Health Center
- Dec 3, 2024BIOMERIEUX INC$200KBacterial ID/SENS Analyzer for Zuni Comprehensive Community Health Center
- Nov 7, 2024Fisher Scientific Company$61KSol_75H70724Q00140 Bactec FX Blood Culture System for Zuni Comprehensive Community Health Center
Competitive landscape
For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Indian Health Service since 2024 (0 filings)
- 0 of their lobbyists list a past Indian Health Service job
- $76K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, House Committee on Natural Resources, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 2 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.